Pharma giant Allergan is under attack in Europe concerning a new weight loss device to hit the market full force, the Lap-Band System. This system was recently U.S. FDA approved for those with a lower body mass index (BMI) than ever before, but is catching some flack in European studies.Bad device news travels fast.
A new study has questioned the long-term effectiveness of the popular Lap-Band weight-loss device, finding that many patients suffered major complications and half of them eventually had the device removed.
Thursday, March 31, 2011
Allergan Gastric Band: Europe Questions Long Term Benefits
It's a worldwide phenom!
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment